1 / 12

Patient safety and reduction of risk of transmission of Creutzfeldt–Jakob disease (CJD) via interventional procedures

Patient safety and reduction of risk of transmission of Creutzfeldt–Jakob disease (CJD) via interventional procedures Implementing NICE guidance 2008 NICE interventional procedure guidance 196 What this presentation covers Background High-risk procedures Recommendations Costs Discussion

Pat_Xavi
Download Presentation

Patient safety and reduction of risk of transmission of Creutzfeldt–Jakob disease (CJD) via interventional procedures

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Patient safety and reduction of risk of transmission of Creutzfeldt–Jakob disease (CJD) via interventional procedures Implementing NICE guidance 2008 NICE interventional procedure guidance 196

  2. What this presentation covers • Background • High-risk procedures • Recommendations • Costs • Discussion • Find out more

  3. Background • What is CJD? • What are prions? • Iatrogenic transmission

  4. High-risk procedures • The high-risk procedures covered by this guidance include: • intradural operations on the brain • posterior eye surgery • excision of eye • operations on vitreous body • photocoagulation of the retina for detachment (only when the retina is handled directly) • destruction of lesion of retina • other operations on the retina • Please see appendix C of the full guidance for a list of all high-risk procedures covered by this guidance (www.nice.org.uk/IPG196).

  5. Recommendations • For high-risk surgical procedures • Use separate pool of instruments for children born since 1st January 1997. • Steps should be taken to ensure that instruments that come into contact with high-risk tissues do not move from one set to another. • Implement strategies to ensure that instruments stay together within sets. • Practice should be audited and systems put in place to track surgical instruments. • All supplementary instruments should be single use or remain with the set to which they have been introduced. • • Hospitals should ensure that an adequate supply of instruments is available.

  6. Recommendations • Neuroendoscopy: • • Use separate pool of neuroendoscopes for children born since 1st January 1997. • • Use rigid neuroendoscopes whenever possible. Thoroughly clean and autoclave after use. • • All accessories should be single use.

  7. Recommendations • Single-use neurosurgery accessories should be: • - manufactured and procured to specifications equivalent to those used for reusable instruments • - quality checked

  8. Other key partners • Department of Health • Advisory Committee on Dangerous Pathogens • Spongiform Encephalopathy Advisory Committee • CJD Incidents Panel • National CJD Surveillance Unit

  9. Costs

  10. For discussion • Which recommendations present the greatest challenge for local practice? • What changes do we need to make to neurosurgery services? • What changes do we need to make to ophthalmic surgical services? • How do we track instruments to stop migration between sets? • What are the next steps to be considered in implementing the guidance locally?

  11. Access tools online • Costing tools: • costing report • costing template • Audit criteria • Available from: www.nice.org.uk/IPG196

  12. Access the guidance online • The guidancewww.nice.org.uk/IPG196 • ‘Understanding NICE guidance’ – a plain English version www.nice.org.uk/nicemedia/pdf/ip/IPG196publicinfo.doc

More Related